Global Ocaliva Market Growth 2022-2028
- LP 4891160
- 76 Pages
- March 2022
- Pharmaceuticals
The United States Ocaliva market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ocaliva market, reaching US$ million by the year 2028. As for the Europe Ocaliva landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ocaliva players cover Intercept Pharmaceuticals, Dainippon Sumitomo Pharma, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ocaliva market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
5mg
10mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Primary Biliary Cirrhosis
Nonalcoholic Fatty Liver Disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Intercept Pharmaceuticals
Dainippon Sumitomo Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ocaliva Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ocaliva by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ocaliva by Country/Region, 2017, 2022 & 2028
2.2 Ocaliva Segment by Type
2.2.1 5mg
2.2.2 10mg
2.3 Ocaliva Sales by Type
2.3.1 Global Ocaliva Sales Market Share by Type (2017-2022)
2.3.2 Global Ocaliva Revenue and Market Share by Type (2017-2022)
2.3.3 Global Ocaliva Sale Price by Type (2017-2022)
2.4 Ocaliva Segment by Application
2.4.1 Primary Biliary Cirrhosis
2.4.2 Nonalcoholic Fatty Liver Disease
2.4.3 Other
2.5 Ocaliva Sales by Application
2.5.1 Global Ocaliva Sale Market Share by Application (2017-2022)
2.5.2 Global Ocaliva Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ocaliva Sale Price by Application (2017-2022)
3 Global Ocaliva by Company
3.1 Global Ocaliva Breakdown Data by Company
3.1.1 Global Ocaliva Annual Sales by Company (2020-2022)
3.1.2 Global Ocaliva Sales Market Share by Company (2020-2022)
3.2 Global Ocaliva Annual Revenue by Company (2020-2022)
3.2.1 Global Ocaliva Revenue by Company (2020-2022)
3.2.2 Global Ocaliva Revenue Market Share by Company (2020-2022)
3.3 Global Ocaliva Sale Price by Company
3.4 Key Manufacturers Ocaliva Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ocaliva Product Location Distribution
3.4.2 Players Ocaliva Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ocaliva by Geographic Region
4.1 World Historic Ocaliva Market Size by Geographic Region (2017-2022)
4.1.1 Global Ocaliva Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ocaliva Annual Revenue by Geographic Region
4.2 World Historic Ocaliva Market Size by Country/Region (2017-2022)
4.2.1 Global Ocaliva Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ocaliva Annual Revenue by Country/Region
4.3 Americas Ocaliva Sales Growth
4.4 APAC Ocaliva Sales Growth
4.5 Europe Ocaliva Sales Growth
4.6 Middle East & Africa Ocaliva Sales Growth
5 Americas
5.1 Americas Ocaliva Sales by Country
5.1.1 Americas Ocaliva Sales by Country (2017-2022)
5.1.2 Americas Ocaliva Revenue by Country (2017-2022)
5.2 Americas Ocaliva Sales by Type
5.3 Americas Ocaliva Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ocaliva Sales by Region
6.1.1 APAC Ocaliva Sales by Region (2017-2022)
6.1.2 APAC Ocaliva Revenue by Region (2017-2022)
6.2 APAC Ocaliva Sales by Type
6.3 APAC Ocaliva Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ocaliva by Country
7.1.1 Europe Ocaliva Sales by Country (2017-2022)
7.1.2 Europe Ocaliva Revenue by Country (2017-2022)
7.2 Europe Ocaliva Sales by Type
7.3 Europe Ocaliva Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ocaliva by Country
8.1.1 Middle East & Africa Ocaliva Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ocaliva Revenue by Country (2017-2022)
8.2 Middle East & Africa Ocaliva Sales by Type
8.3 Middle East & Africa Ocaliva Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ocaliva
10.3 Manufacturing Process Analysis of Ocaliva
10.4 Industry Chain Structure of Ocaliva
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ocaliva Distributors
11.3 Ocaliva Customer
12 World Forecast Review for Ocaliva by Geographic Region
12.1 Global Ocaliva Market Size Forecast by Region
12.1.1 Global Ocaliva Forecast by Region (2023-2028)
12.1.2 Global Ocaliva Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ocaliva Forecast by Type
12.7 Global Ocaliva Forecast by Application
13 Key Players Analysis
13.1 Intercept Pharmaceuticals
13.1.1 Intercept Pharmaceuticals Company Information
13.1.2 Intercept Pharmaceuticals Ocaliva Product Offered
13.1.3 Intercept Pharmaceuticals Ocaliva Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Intercept Pharmaceuticals Main Business Overview
13.1.5 Intercept Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Ocaliva Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Ocaliva Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 5mg
Table 4. Major Players of 10mg
Table 5. Global Ocaliva Sales by Type (2017-2022) & (K Units)
Table 6. Global Ocaliva Sales Market Share by Type (2017-2022)
Table 7. Global Ocaliva Revenue by Type (2017-2022) & ($ million)
Table 8. Global Ocaliva Revenue Market Share by Type (2017-2022)
Table 9. Global Ocaliva Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Ocaliva Sales by Application (2017-2022) & (K Units)
Table 11. Global Ocaliva Sales Market Share by Application (2017-2022)
Table 12. Global Ocaliva Revenue by Application (2017-2022)
Table 13. Global Ocaliva Revenue Market Share by Application (2017-2022)
Table 14. Global Ocaliva Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Ocaliva Sales by Company (2020-2022) & (K Units)
Table 16. Global Ocaliva Sales Market Share by Company (2020-2022)
Table 17. Global Ocaliva Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Ocaliva Revenue Market Share by Company (2020-2022)
Table 19. Global Ocaliva Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Ocaliva Producing Area Distribution and Sales Area
Table 21. Players Ocaliva Products Offered
Table 22. Ocaliva Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Ocaliva Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Ocaliva Sales Market Share Geographic Region (2017-2022)
Table 27. Global Ocaliva Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Ocaliva Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Ocaliva Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Ocaliva Sales Market Share by Country/Region (2017-2022)
Table 31. Global Ocaliva Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Ocaliva Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Ocaliva Sales by Country (2017-2022) & (K Units)
Table 34. Americas Ocaliva Sales Market Share by Country (2017-2022)
Table 35. Americas Ocaliva Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Ocaliva Revenue Market Share by Country (2017-2022)
Table 37. Americas Ocaliva Sales by Type (2017-2022) & (K Units)
Table 38. Americas Ocaliva Sales Market Share by Type (2017-2022)
Table 39. Americas Ocaliva Sales by Application (2017-2022) & (K Units)
Table 40. Americas Ocaliva Sales Market Share by Application (2017-2022)
Table 41. APAC Ocaliva Sales by Region (2017-2022) & (K Units)
Table 42. APAC Ocaliva Sales Market Share by Region (2017-2022)
Table 43. APAC Ocaliva Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Ocaliva Revenue Market Share by Region (2017-2022)
Table 45. APAC Ocaliva Sales by Type (2017-2022) & (K Units)
Table 46. APAC Ocaliva Sales Market Share by Type (2017-2022)
Table 47. APAC Ocaliva Sales by Application (2017-2022) & (K Units)
Table 48. APAC Ocaliva Sales Market Share by Application (2017-2022)
Table 49. Europe Ocaliva Sales by Country (2017-2022) & (K Units)
Table 50. Europe Ocaliva Sales Market Share by Country (2017-2022)
Table 51. Europe Ocaliva Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Ocaliva Revenue Market Share by Country (2017-2022)
Table 53. Europe Ocaliva Sales by Type (2017-2022) & (K Units)
Table 54. Europe Ocaliva Sales Market Share by Type (2017-2022)
Table 55. Europe Ocaliva Sales by Application (2017-2022) & (K Units)
Table 56. Europe Ocaliva Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Ocaliva Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Ocaliva Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Ocaliva Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Ocaliva Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Ocaliva Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Ocaliva Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Ocaliva Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Ocaliva Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Ocaliva
Table 66. Key Market Challenges & Risks of Ocaliva
Table 67. Key Industry Trends of Ocaliva
Table 68. Ocaliva Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Ocaliva Distributors List
Table 71. Ocaliva Customer List
Table 72. Global Ocaliva Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Ocaliva Sales Market Forecast by Region
Table 74. Global Ocaliva Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Ocaliva Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Ocaliva Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Ocaliva Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Ocaliva Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Ocaliva Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Ocaliva Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Ocaliva Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Ocaliva Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Ocaliva Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Ocaliva Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Ocaliva Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Ocaliva Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Ocaliva Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Ocaliva Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Ocaliva Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Ocaliva Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Ocaliva Revenue Market Share Forecast by Application (2023-2028)
Table 92. Intercept Pharmaceuticals Basic Information, Ocaliva Manufacturing Base, Sales Area and Its Competitors
Table 93. Intercept Pharmaceuticals Ocaliva Product Offered
Table 94. Intercept Pharmaceuticals Ocaliva Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Intercept Pharmaceuticals Main Business
Table 96. Intercept Pharmaceuticals Latest Developments
Table 97. Dainippon Sumitomo Pharma Basic Information, Ocaliva Manufacturing Base, Sales Area and Its Competitors
Table 98. Dainippon Sumitomo Pharma Ocaliva Product Offered
Table 99. Dainippon Sumitomo Pharma Ocaliva Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Dainippon Sumitomo Pharma Main Business
Table 101. Dainippon Sumitomo Pharma Latest Developments
List of Figures
Figure 1. Picture of Ocaliva
Figure 2. Ocaliva Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ocaliva Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Ocaliva Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Ocaliva Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 5mg
Figure 10. Product Picture of 10mg
Figure 11. Global Ocaliva Sales Market Share by Type in 2021
Figure 12. Global Ocaliva Revenue Market Share by Type (2017-2022)
Figure 13. Ocaliva Consumed in Primary Biliary Cirrhosis
Figure 14. Global Ocaliva Market: Primary Biliary Cirrhosis (2017-2022) & (K Units)
Figure 15. Ocaliva Consumed in Nonalcoholic Fatty Liver Disease
Figure 16. Global Ocaliva Market: Nonalcoholic Fatty Liver Disease (2017-2022) & (K Units)
Figure 17. Ocaliva Consumed in Other
Figure 18. Global Ocaliva Market: Other (2017-2022) & (K Units)
Figure 19. Global Ocaliva Sales Market Share by Application (2017-2022)
Figure 20. Global Ocaliva Revenue Market Share by Application in 2021
Figure 21. Ocaliva Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Ocaliva Revenue Market Share by Company in 2021
Figure 23. Global Ocaliva Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Ocaliva Revenue Market Share by Geographic Region in 2021
Figure 25. Global Ocaliva Sales Market Share by Region (2017-2022)
Figure 26. Global Ocaliva Revenue Market Share by Country/Region in 2021
Figure 27. Americas Ocaliva Sales 2017-2022 (K Units)
Figure 28. Americas Ocaliva Revenue 2017-2022 ($ Millions)
Figure 29. APAC Ocaliva Sales 2017-2022 (K Units)
Figure 30. APAC Ocaliva Revenue 2017-2022 ($ Millions)
Figure 31. Europe Ocaliva Sales 2017-2022 (K Units)
Figure 32. Europe Ocaliva Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Ocaliva Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Ocaliva Revenue 2017-2022 ($ Millions)
Figure 35. Americas Ocaliva Sales Market Share by Country in 2021
Figure 36. Americas Ocaliva Revenue Market Share by Country in 2021
Figure 37. United States Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Ocaliva Sales Market Share by Region in 2021
Figure 42. APAC Ocaliva Revenue Market Share by Regions in 2021
Figure 43. China Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Ocaliva Sales Market Share by Country in 2021
Figure 50. Europe Ocaliva Revenue Market Share by Country in 2021
Figure 51. Germany Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Ocaliva Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Ocaliva Revenue Market Share by Country in 2021
Figure 58. Egypt Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Ocaliva Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Ocaliva in 2021
Figure 64. Manufacturing Process Analysis of Ocaliva
Figure 65. Industry Chain Structure of Ocaliva
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
